The cGAS–STING pathway and cancer

N Samson, A Ablasser - Nature cancer, 2022 - nature.com
The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway has
emerged as a critical innate immune pathway that, following engagement by DNA, promotes …

Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy

KM Garland, TL Sheehy, JT Wilson - Chemical reviews, 2022 - ACS Publications
The stimulator of interferon genes (STING) cellular signaling pathway is a promising target
for cancer immunotherapy. Activation of the intracellular STING protein triggers the …

Bioorthogonal guided activation of cGAS‐STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging

M Cui, D Tang, B Wang, H Zhang, G Liang… - Advanced …, 2023 - Wiley Online Library
Photodynamic therapy (PDT) and photothermal therapy (PTT) leverage reactive oxygen
species (ROS) and control local hyperthermia by photosensitizer to perturb intracellular …

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

M McLaughlin, EC Patin, M Pedersen, A Wilkins… - Nature Reviews …, 2020 - nature.com
The development of immune checkpoint inhibitors (ICIs) is revolutionizing the way we think
about cancer treatment. Even so, for most types of cancer, only a minority of patients …

The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion

U Uslu, L Sun, S Castelli, AV Finck… - Nature …, 2024 - nature.com
As a strategy to improve the therapeutic success of chimeric antigen receptor T cells (CART)
directed against solid tumors, we here test the combinatorial use of CART and IMSA101, a …

Dendritic cells and their role in immunotherapy

A Gardner, Á de Mingo Pulido, B Ruffell - Frontiers in immunology, 2020 - frontiersin.org
Despite significant advances in the field of cancer immunotherapy, the majority of patients
still do not benefit from treatment and must rely on traditional therapies. Dendritic cells have …

Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

M Orth, P Metzger, S Gerum, J Mayerle, G Schneider… - Radiation …, 2019 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor
prognosis and rising incidence. Late detection and a particularly aggressive biology are the …

[HTML][HTML] Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer

S Hegde, VE Krisnawan, BH Herzog, C Zuo… - Cancer cell, 2020 - cell.com
Here, we utilized spontaneous models of pancreatic and lung cancer to examine how
neoantigenicity shapes tumor immunity and progression. As expected, neoantigen …

The multifaceted role of chromosomal instability in cancer and its microenvironment

SF Bakhoum, LC Cantley - Cell, 2018 - cell.com
Chromosomal instability (CIN) is a hallmark of human cancer, and it is associated with poor
prognosis, metastasis, and therapeutic resistance. CIN results from errors in chromosome …

Targeting neoantigens to augment antitumour immunity

M Yarchoan, BA Johnson III, ER Lutz… - Nature Reviews …, 2017 - nature.com
The past decade of cancer research has been marked by a growing appreciation of the role
of immunity in cancer. Mutations in the tumour genome can cause tumours to express …